Kinetic Characterization of PB1-F2-Mediated Immunopathology during Highly Pathogenic Avian H5N1 Influenza Virus Infection

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Leymarie, Olivier ^a   Jouvion, Grégory ^b   Hervé, Pierre Louis ^c,d,e   Chevalier, Christophe ^a   Lorin, Valérie ^c,d,e   Lecardonnel, Jérôme ^f   Da Costa, Bruno ^a   Delmas, Bernard ^a   Escriou, Nicolas ^c,d,e   Le Goffic, Ronan ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b INSTITUT PASTEUR   (France)

^c Sorbonne Paris Cité   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PB1 F2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRANULOCYTE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MACROPHAGE ACTIVATION; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTOMICS; VIRUS MUTANT; VIRUS PNEUMONIA; VIRUS RECOMBINANT;

ANIMALS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKOUT TECHNIQUES; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS, H5N1 SUBTYPE; KILLER CELLS, NATURAL; LUNG; MICE; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RESPIRATORY MUCOSA; SPECIES SPECIFICITY; SURVIVAL RATE; TRANSCRIPTOME; VIRAL PROTEINS; VIRULENCE;

EID: 84874559777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057894     Document Type: Article

References (54)

1. Malik Peiris JS, (2009) Avian influenza viruses in humans. Rev Sci Tech 28: 161-173.
2. Yen HL, Webster RG, (2009) Pandemic influenza as a current threat. Curr Top Microbiol Immunol 333: 3-24.
3. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng H, et al. (2008) Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A 105: 3064-3069.
4. Peiris JS, Cheung CY, Leung CY, Nicholls JM, (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30: 574-584.
5. Osterholm MT, (2005) Preparing for the next pandemic. N Engl J Med 352: 1839-1842.
6. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
7. Kash JC, Basler CF, Garcia-Sastre A, Carter V, Billharz R, et al. (2004) Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 78: 9499-9511.
8. Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, et al. (2001) Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A 98: 2746-2751.
9. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431: 703-707.
10. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, et al. (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2: 240-249.
11. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P, (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3: 1414-1421.
12. Zamarin D, Ortigoza MB, Palese P, (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80: 7976-7983.
13. Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, et al. (2011) Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species. PLoS Pathog 7: e1002186.
14. Marjuki H, Scholtissek C, Franks J, Negovetich NJ, Aldridge JR, et al. (2010) Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol 155: 925-934.
15. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7: 1306-1312.
16. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, et al. (2009) A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83: 8021-8031.
17. Le Goffic R, Leymarie O, Chevalier C, Rebours E, Da Costa B, et al. (2011) Transcriptomic Analysis of Host Immune and Cell Death Responses Associated with the Influenza A Virus PB1-F2 Protein. PLoS Pathog 7: e1002202.
18. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P, (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1: e4.
19. McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, et al. (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6: e1001014.
20. Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, et al. (2010) Influenza A Virus Protein PB1-F2 Exacerbates IFN-{beta} Expression of Human Respiratory Epithelial Cells. J Immunol 185: 4812-4823.
21. Varga ZT, Grant A, Manicassamy B, Palese P, (2012) Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon by Binding to MAVS and Decreasing Mitochondrial Membrane Potential. J Virol 86: 8359-8366.
22. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, et al. (2011) The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 392: 1135-1144.
23. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, et al. (2011) A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol 85: 652-662.
24. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW, (2003) The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77: 7214-7224.
25. Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, et al. (2007) Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88: 536-546.
26. McAuley JL, Zhang K, McCullers JA, (2010) The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84: 558-564.
27. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type i interferon at the level of the MAVS adaptor protein. PLoS Pathog 7: e1002067.
28. Pena L, Vincent AL, Loving CL, Henningson JN, Lager KM,et al. (2012) Restoring PB1-F2 into the 2009 Pandemic H1N1 Influenza Virus has minimal effects in swine. J Virol.
29. Ozawa M, Basnet S, Burley LM, Neumann G, Hatta M, et al. (2011) Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol 85: 4596-4601.
30. Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, et al. (2010) PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84: 4442-4450.
31. Meunier I, von Messling V, (2012) PB1-F2 Modulates Early Host Responses but Does Not Affect the Pathogenesis of H1N1 Seasonal Influenza Virus. J Virol 86: 4271-4278.
32. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U,et al. (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol.
33. Guo H, Kumar P, Malarkannan S, (2011) Evasion of natural killer cells by influenza virus. J Leukoc Biol 89: 189-194.
34. Coleman JR, (2007) The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4: 9.
35. Varga ZT, Palese P, (2011) The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence 2: 542-546.
36. Fragiadaki M, Ikeda T, Witherden A, Mason RM, Abraham D, et al. (2011) High doses of TGF-beta potently suppress type I collagen via the transcription factor CUX1. Mol Biol Cell 22: 1836-1844.
37. Ivan FX, Rajapakse JC, Welsch RE, Rozen SG, Narasaraju T, et al. (2012) Differential pulmonary transcriptomic profiles in murine lungs infected with low and highly virulent influenza H3N2 viruses reveal dysregulation of TREM1 signaling, cytokines, and chemokines. Funct Integr Genomics 12: 105-117.
38. Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, et al. (2005) Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem 280: 13952-13961.
39. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
40. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, et al. (2006) The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 80: 11115-11123.
41. Seo SH, Hoffmann E, Webster RG, (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8: 950-954.
42. NCBI_Influenza_Virus_Resource_Database. Available:http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html. Accessed 2012 May 15.
43. Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, et al. (2009) Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 5: e1000604.
44. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A, (2008) HMGB1: endogenous danger signaling. Mol Med 14: 476-484.
45. Wilson CB, Ray M, Lutz M, Sharda D, Xu J, et al. (2008) The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J Immunol 181: 2303-2310.
46. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, et al. (2004) PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 78: 6304-6312.
47. Chevalier C, Al Bazzal A, Vidic J, Fevrier V, Bourdieu C, et al. (2010) PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem 285: 13233-13243.
48. Henkel M, Mitzner D, Henklein P, Meyer-Almes FJ, Moroni A, et al. (2010) The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One 5: e11112.
49. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, et al. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263-266.
50. Sun J, Madan R, Karp CL, Braciale TJ, (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15: 277-284.
51. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG, (2002) Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
52. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
53. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108-6113.
54. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoints. Amer J Hyg 27: 493-497.